ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase InhibitorsFederica Lovisa(Azienda Ospedaliera di Padova), Paolo Bonvini(University of Padua)PLoS ONEApril 13, 201510.1371/journal.pone.0121378Cited by 9SaveCiteExport RISWatch citationsRelated PapersHigh ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma|British Journal of Cancer|2013|25Understanding the Interplay between Expression, Mutation and Activity of ALK Receptor in Rhabdomyosarcoma Cells for Clinical Application of Small-Molecule Inhibitors|PLoS ONE|2015|15